BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19566749)

  • 1. The role of nitric oxide in A3 adenosine receptor-mediated cardioprotection.
    Hussain A; Karjian P; Maddock H
    Auton Autacoid Pharmacol; 2009 Jul; 29(3):97-104. PubMed ID: 19566749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signalling pathways in ischaemic postconditioning.
    Hausenloy DJ
    Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IB-MECA and cardioprotection.
    Xu Z; Jang Y; Mueller RA; Norfleet EA
    Cardiovasc Drug Rev; 2006; 24(3-4):227-38. PubMed ID: 17214599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
    Xu X; Cao Z; Cao B; Li J; Guo L; Que L; Ha T; Chen Q; Li C; Li Y
    Surgery; 2009 Sep; 146(3):506-14. PubMed ID: 19715808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preconditioning and postconditioning: new strategies for cardioprotection.
    Hausenloy DJ; Yellon DM
    Diabetes Obes Metab; 2008 Jun; 10(6):451-9. PubMed ID: 17825079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin: ready for prime-time cardioprotection.
    Riksen NP; Hausenloy DJ; Yellon DM
    Trends Pharmacol Sci; 2008 May; 29(5):258-67. PubMed ID: 18359096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reperfusion in STEMI patients: still a role for cardioprotection?
    Ottani F; Limbruno U; Latini R; Misuraca L; Galvani M
    Minerva Cardioangiol; 2018 Aug; 66(4):452-463. PubMed ID: 29589674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of mitochondrial permeability transition pore opening: translation to patients.
    Gomez L; Li B; Mewton N; Sanchez I; Piot C; Elbaz M; Ovize M
    Cardiovasc Res; 2009 Jul; 83(2):226-33. PubMed ID: 19221132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotection with adenosine: 'a riddle wrapped in a mystery'.
    Przyklenk K; Whittaker P
    Br J Pharmacol; 2005 Jul; 145(6):699-700. PubMed ID: 15895103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A3 adenosine receptor-mediated protection of the ischemic heart.
    Headrick JP; Peart J
    Vascul Pharmacol; 2005; 42(5-6):271-9. PubMed ID: 15922260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological targets revealed by myocardial postconditioning.
    Burley DS; Baxter GF
    Curr Opin Pharmacol; 2009 Apr; 9(2):177-88. PubMed ID: 19109069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment with Tongxinluo protects porcine myocardium from ischaemia/reperfusion injury through a nitric oxide related mechanism.
    Cheng YT; Yang YJ; Zhang HT; Qian HY; Zhao JL; Meng XM; Luo FL; Wu YL
    Chin Med J (Engl); 2009 Jul; 122(13):1529-38. PubMed ID: 19719943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter by Greyson regarding article, "High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury".
    Greyson CR
    Circulation; 2008 Nov; 118(21):e703; author reply e704. PubMed ID: 19015409
    [No Abstract]   [Full Text] [Related]  

  • 14. The A3 adenosine receptor: an enigmatic player in cell biology.
    Gessi S; Merighi S; Varani K; Leung E; Mac Lennan S; Borea PA
    Pharmacol Ther; 2008 Jan; 117(1):123-40. PubMed ID: 18029023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A3 receptor and cardioprotection: enticing, enigmatic, elusive.
    Rothermel BA; Hill JA
    Circulation; 2008 Oct; 118(17):1691-3. PubMed ID: 18936336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery.
    De Hert S; Vlasselaers D; Barbé R; Ory JP; Dekegel D; Donnadonni R; Demeere JL; Mulier J; Wouters P
    Anaesthesia; 2009 Sep; 64(9):953-60. PubMed ID: 19686479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter by Tsikas and Rossi regarding article, "Nitrite anion provides potent cytoprotective and antiapoptotic effects as adjunctive therapy to reperfusion for acute myocardial infarction".
    Tsikas D; Rossi R
    Circulation; 2009 May; 119(19):e531; author reply e532. PubMed ID: 19451359
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardioprotection in anesthesia.
    De Hert SG
    Minerva Anestesiol; 2008 Jun; 74(6):259-70. PubMed ID: 18500198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial protection during heart surgery in China.
    Ji B; Liu J
    Chin Med J (Engl); 2007 Jan; 120(1):62-7. PubMed ID: 17254490
    [No Abstract]   [Full Text] [Related]  

  • 20. A3 adenosine receptor: pharmacology and role in disease.
    Borea PA; Gessi S; Bar-Yehuda S; Fishman P
    Handb Exp Pharmacol; 2009; (193):297-327. PubMed ID: 19639286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.